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Abstract
Acute Lung Injury (ALI) carries about 50 percent mortality and is frequently associated with an infection (sepsis). Life-
support treatment with mechanical ventilation rescues many patients, although superimposed infection or multiple organ
failure can result in death. The outcome of a patient developing sepsis depends on two factors: the infection and the pre-
existing inflammation. In this study, we described each stage of the inflammation process using a transcriptional approach
and an animal model. Female C57BL6/J mice received an intravenous oleic acid injection to induce an acute lung injury
(ALI). Lung expression patterns were analyzed using a 9900 cDNA mouse microarray (MUSV29K). Our gene-expression
analysis revealed marked changes in the immune and inflammatory response metabolic pathways, notably lipid metabolism
and transcription. The early stage (1 hour–1.5 hours) is characterized by a pro-inflammatory immune response. Later
(3 hours–4 hours), the immune cells migrate into inflamed tissues through interaction with vascular endothelial cells.
Finally, at late stages of lung inflammation (18 hours–24 hours), metabolism is deeply disturbed. Highly expressed pro-
inflammatory cytokines activate transcription of many genes and lipid metabolism. In this study, we described a global
overview of critical events occurring during lung inflammation which is essential to understand infectious pathologies such
as sepsis where inflammation and infection are intertwined. Based on these data, it becomes possible to isolate the impact
of a pathogen at the transcriptional level from the global gene expression modifications resulting from the infection
associated with the inflammation.
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Introduction
Acute lung injury (ALI) is a diffuse lung injury which is
characterized by a widespread capillary leakage leading to
hypoxemia and low lung compliance. ALI is caused by either a
direct (e.g. pneumonia) or indirect (e.g. pancreatitis) injury of the
lung. Any local (e.g. pneumonia) or systemic inflammation (e.g.
pancreatitis) can lead to a critical alteration of the lung function.
The Acute Respiratory Distress Syndrome (ARDS) is the last stage
of this acute inflammatory process and still carries a high mortality
rate (40–50%) [1]. Sepsis is a major cause of ARDS either by
direct alteration of the lung or indirectly through the Systemic
Inflammatory Response Syndrome (SIRS) associated with severe
sepsis. Inflammation is part of the defense mechanisms of innate
immunity, occurring after tissue injury. At the site of inflamma-
tion, a cascade of mediators such as cytokines initiates activation of
inflammatory cells (early-inflammatory phase). Then, white blood
cells migrate through the wall of blood vessels and infiltrate the
surrounding tissues. ARDS frequently occurs in a context of severe
sepsis in which inflammation and infection interplay. Then, it is
unclear to delineate the pathways related to inflammation or
infection. In sepsis, the production of both pro- and anti-
inflammatory cytokines in sepsis has been widely studied [2].
While pro-inflammatory cytokines are necessary for initiating an
effective inflammatory process against infection, anti-inflammatory
cytokines seem to be a prerequisite for controlling and down-
regulating the inflammatory response leading to a depression of
the immune system of patients [3]. Human immune responses to
sepsis are mediated mainly by the primary pro-inflammatory
cytokines. The timing of cytokine release and the balance between
pro- and anti-inflammatory mediators seems to be associated with
the severity of sepsis [4–5]. An excessive production may induce
deleterious effects [5]. To this purpose, deciphering gene
expression profiles of either infection or inflammation alone seems
crucial.
One way to do so consists on studying transcriptional genes
expression profiles at several inflammation stages (with or without
sepsis). Genome-wide gene expression profiling using microarray
technology has been applied successfully to the study of human
disease pathogenesis. Examples include the discovery of new
cancer subtypes with different prognosis and response to therapies
[6], or new hypotheses of disease pathogenesis in ARDS [7]. Gene
expression analysis by microarray studies of genes clusters that
have similar expression changes over time allows the definition of
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been successfully used to study either ARDS, using either a whole
organ or cultured cells or in severe sepsis studies where
inflammation was associated with infection [8].
In humans with ARDS, time-course studies using blood samples
made it possible to obtain successful results using a transcriptional
approach. Wang et al. studied global gene expression profiling in 8
human blood samples and identified potential candidate genes that
can be used as biomarkers for ARDS [9]. They reported for
instance the role of peptidase inhibitor 3 (Serpina1c/PI3) encoding
Elafin which has antimicrobial and anti-inflammatory activities.
One limitation in using human samples is the heterogeneity of the
samples with patients from different gender, age, injury, ethnic
origin and genetic backgrounds.
Previous transcriptional studies performed to study ARDS used
various experimental techniques, various species and various types
of infection. The common point between these studies is the
sequence of events: first, an infection is associated with an
inflammation and then, samples are studied using a transcriptional
approach. At this point, since gene expression patterns depend on
both inflammation and infection, it is not possible to identify the
impact of either inflammation or infection on gene expression. A
similar infective agent leads to different outcomes depending on
the pre-existent inflammation stage of each patient [4]. For this
reason, we decided to set up a mouse model to study ALI without
any infection. Inflammation induced by intravenous administra-
tion of Oleic Acid (OA) resembles ARDS in many morphological,
histological, and physiological respects [10]. OA-induced ALI is
consistently associated with acute respiratory failure characterized
by hypoxemia and reduced lung compliance due to alveolar
damage, intra-alveolar hemorrhage, and leakage of proteinaceous
fluid into the air space [11]. The progression of OA-induced injury
is much shorter than that of human ARDS. The acute phase of
human ARDS develops over 1–7 days. However, it is also
characterized by extensive damage to the alveolar epithelium,
hemorrhage, and pulmonary edema. Despite some limitations, the
OA-ALI remains a relevant model for investigating the effects of
ALI. Indeed, no other model has been used as extensively to
evaluate the risks and benefits of various treatment strategies
before applying them to patients with ARDS [10].
Our objective was to identify some biologically relevant process
important in ALI by studying the molecular interactions between
OA and inflammation in a mouse model. The modest success of
microarray approaches to identify novel potential therapeutic
targets may be due to a lack of comprehension to how changes in
gene expression occur through time. For this reason, we decided to
investigate lung gene expression patterns in female mice
developing inflammation without any infection using a 9900
cDNA mouse microarray over a 24 hours time-course. By looking
at changes in gene expression over time, we developed a global
strategy to identify novel pathways that could represent novel
targets for therapy.
Results
Outcome of mice and definition of pro- and anti-
inflammatory phases by real-time PCR
Following the injection of OA, we noticed a transitional
prostration of the mice which started 1.5 hours after injection
and lasted for several hours. All mice recovered; the survival rate
was 100% after 24 hours incubation. To evaluate for the
incubation period necessary to induce lung inflammation, we
considered a wide time-course ranging from 1 hour to 24 hours
after OA injection even if previously published studies considered
much shorter incubation times [12–13]. Prior to large-scale gene
expression analysis, we quantified expression level of one pro-
inflammatory cytokine (Tnfa), one cytokine with pro- and anti-
inflammatory activities (Il6), and two anti-inflammatory cytokines
(Il10 and Il4) at 1 hour, 1.5 hours, 3 hours, 4 hours, 18 hours and
24 hours after OA and physiological serum injection (figure 1 A).
Expression levels of Tnfa, Il6, Il10 and Il4 peaked respectively at
1.5 hours, 3 hours, 4 hours and 3 hours-4 hours after OA
injection. Thus, inflammatory response ranged from 60 minutes
to several hours following OA injection. Real-time PCR allowed
us to identify a pro-inflammatory expression peak 1.5 hours after
OA injection (figure 1 B), a transition phase 3 hours to 4 hours
after OA injection (figure 1 C) and an anti-inflammatory phase
4 hours after OA injection (figure 1 D, E).
Identification of the inflammation timing following OA
injection using lung histology
Compared with physiological serum controls, OA induced a
transient increase in histological lung damage 1.5 hours after
injection (figure 2). Histologically, 1.5 hours after OA injection, we
found a neutrophil accumulation in the alveolar wall associated
with edema. Lung histological modifications are thus correlated
with the transcriptional up-regulation of pro-inflammatory
mediators (both by microarray and RT-PCR). These results
strengthened our real-time PCR data. There were no more
histological lung lesions 3 hours after OA injection.
Microarray analysis discriminated between early- and
late-inflammatory stages according to the time-course
after injection
To focus on transcriptional changes associated with the
inflammatory process in lung, we searched for a set of genes that
discriminated between mice at different incubation times. To this
purpose, we used the multi-class SAM procedure [14], and we
applied a false discovery rate of 5% (figure 3 and see
supplementary data file S1). The analysis yielded a set of 1000
genes (see supplementary data file S2). By performing a
hierarchical clustering of the samples (microarrays), we identified
3 clusters (see supplementary data file S3). Samples at 1 hour and
1.5 hours clustered together. The same way, samples at 3 hours
and 4 hours were grouped together. Finally, samples at 18 hours
and 24 hours clustered together with the exception of three
18 hours samples which have been grouped with the 3 hours–
4 hours cluster as an out-group.
We also performed unsupervised hierarchical clustering on the
1000 genes (figure 4).Interestingly, the expression level of numerous
genes was induced specifically either early or late after OA injection
while other genes were specifically up-regulated during the
transition phase between the early- and late-inflammatory stages
(see supplementary data file S4). The Cluster software [15] classified
the 1000 significantly differentially expressed genes into 3 main
clusters. Genes of cluster Early (365 genes) were over-expressed at
early stage of inflammation (1 hour–1.5 hours); their expression
level decreased at 3–4 hours and then these genes were under-
expressed at late time-points (18 hours–24 hours). Genes of the
Intermediate cluster (269 genes) were over-expressed between
1.5 hours and 4 hours compared to the earliest time-point (1 hour)
and the late measurements (18 hours –24 hours), which correspond
to the transition between early- and late-inflammatory responses. At
the latest stage of inflammation, genes from the Late cluster (366
genes) were highly over-expressed. Expression level of these genes
increased at 3 hours to 4 hours after OA injection and reached a
peak at 18 hours–24 hours.
Gene Expression of ALI in Mice
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inflammation, we considered biological process Gene Ontology
(GO) terms, Kegg pathways and the Biocarta database using
DAVID for the 365 genes belonging to the cluster Early, the 269
genes belonging to the cluster Intermediate, and the 366 genes
belonging to the cluster Late.
GO terms related to the «Defense response» (p=9.9610
23)
such as «Inflammatory response» (p=6.9610
23), ‘‘cytokine
activity’’ (p=1.1610
22) and «Immune response» (p=6.5610
23)
were strongly represented in cluster Early (table 1). Similarly,
several genes grouped in the cluster Early were found to be
involved in Kegg pathways related to immune responses such as
Figure 2. Histological quantification of lung injury following OA injection. Sections are representative of all animals examined per group. A-
Section of lung 1H30 after OA injection showing interstitial neutrophils (n) and edema (e). There was no significant fibrin formation within the
alveolar spaces – B- Section of lung 3H00 after OA injection showing absence of edema or fibrin. There was no more significant neutrophil infiltrate -
(tb) Terminal bronchiole. (H&E x100, cartridges X400).
doi:10.1371/journal.pone.0011485.g002
Figure 1. Variation of expression of pro-inflammatory and anti-inflammatory cytokines determined by real-time RT-PCR in lung
samples. The X-axis corresponds to the incubation time after OA injection. The Y-axis corresponds to the ratio between the expression level of a
cytokine measured after OA injection and the expression level of this same cytokine measured after the same incubation time following physiological
serum injection. Measurements are normalized using the bactin housekeeping gene. A- Variations of expression level of Tnfa, Il6, Il10 and Il4 across
OA incubation time allowed us to identify pro- and anti-inflammatory phases. B- We identified the pro-inflammatory peak 1H30 after injection of OA
which corresponds to the maximum expression level of Tnfa. C- Il6 which is both a pro- and anti-inflammatory cytokine is highly expressed 3H after
OA injection. D- The expression level of Il10, an anti-inflammatory cytokine is maximal 4H after injection of OA. E- Il4 is highly expressed 3H to 4H after
injection of OA. We observe that the anti-inflammatory response occurs approximately 4H after OA injection and follows the pro-inflammatory
response which occurs approximately 1H30 after OA injection.
doi:10.1371/journal.pone.0011485.g001
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22). The Functional
Annotation Clustering tool from DAVID grouped these terms in
a single annotation cluster with the best enrichment score (1.36).
Nine genes belonging to the «Hematopoietic cell lineage» pathway
(p=6.5610
22) were present in this cluster. As expected in
inflammation response, immune and pro-inflammatory responses
are activated. These results validate our experimental strategy,
particularly the use of OA to induce a reliable inflammation
without any infection.
Most of the genes grouped in the cluster Intermediate were found
to be involved in Kegg pathways related to the immune response,
notably the spreading of immune cells into inflamed tissues through
interaction with vascular endothelial cells, such as «Leukocyte
Transendothelialmigration»(p=7.8610
23)or«Adherensjunction»
(p=3.5610
22) (table 2). This was further supported by the analysis
of Biocarta Pathway, which pointed out several pathways such as
«Adhesion Molecules on Lymphocyte» (p=8.5610
23)a n d« M o n o -
cyte and its Surface Molecules» (p=1.8610
22). These pathways
wereclusteredtogetherbytheFunctionalAnnotationClusteringtool
Figure 3. Schematic outline of data analysis.
a We compared gene
expression between three groups: 1H-1H30/3H-4H/18H-24H.
b HCL:
Hierarchical Clustering. We considered the full dataset (n=6622 genes)
to identify genes significantly differentially expressed between the
three classes previously described. The 1000 genes identified with SAM
have been clustered using the Cluster software and each cluster was
independently functionally annotated using DAVID.
doi:10.1371/journal.pone.0011485.g003
Figure 4. Hierarchical classification of 1000 significant genes
differentially expressed at early and late stages of inflamma-
tion. This set of genes was extracted from the full dataset (n=9984) by
use of a SAM procedure and a false discovery rate of 5%. Each row
represents a gene and each column represents a sample. Red and green
indicate expression levels respectively above and below the median.
Dendrogram of genes, to the left of the matrix represents overall
similarities in gene expression profiles. 3 clusters have been identified:
Early, Intermediate and Late.
doi:10.1371/journal.pone.0011485.g004
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Functional classification
Database Term Count P-Value
Gene Ontology Immune response 23 6.50E-03
Gene Ontology Inflammatory response 14 6.90E-03
Gene Ontology Defense response 18 9.90E-03
Gene Ontology Cytokine activity 13 1.10E-02
Kegg pathway MAPK signaling pathway 16 1.40E-02
Gene Ontology Response to wounding 16 1.90E-02
Gene Ontology Immune system process 30 2.30E-02
Gene Ontology Protein kinase cascade 14 3.10E-02
Gene Ontology Positive regulation of kinase activity 8 3.30E-02
Gene Ontology Chemokine activity 6 5.00E-02
Gene Ontology MAP kinase tyrosine/serine/threonine phosphatase activity 3 5.10E-02
Gene Ontology MAP kinase phosphatase activity 3 5.10E-02
Gene Ontology Chemokine receptor binding 6 5.60E-02
Kegg pathway Hematopoietic cell lineage 9 6.50E-02
Gene Ontology Interleukin-1 receptor binding 3 6.90E-02
Gene Ontology MAPKKK cascade 7 7.40E-02
Annotation Cluster 1 Enrichment score: 1.36
Database Term Count P-Value
Gene ontology Immune response 23 6.50E-03
Gene ontology Inflammatory response 14 6.90E-03
Gene ontology Defense response 18 9.90E-03
Gene ontology Cytokine activity 13 1.10E-02
Gene ontology Response to wounding 16 1.90E-02
Gene ontology Immune system process 30 2.30E-02
Gene ontology Response to external stimulus 19 3.30E-02
Gene ontology Chemokine activity 6 5.00E-02
Gene ontology Chemokine receptor binding 6 5.60E-02
doi:10.1371/journal.pone.0011485.t001
Table 2. Functional annotation and enrichment of the 269 genes belonging to cluster Intermediate.
Functional classification
Database Term Count P-Value
Kegg pathway Leukocyte transendothelial migration 8 7.80E-03
Biocarta Adhesion molecules on lymphocyte 4 8.50E-03
Biocarta Neutrophil and its surface molecules 4 8.50E-03
Biocarta Monocyte and its surface molecules 4 1.80E-02
Kegg pathway Adherens junction 6 3.50E-02
Kegg pathway Hematopoietic cell lineage 7 4.20E-02
Annotation Cluster 1 Enrichment score: 1.16
Database Term Count P-Value
Biocarta Adhesion molecules on lymphocyte 4 8.50E-03
Biocarta Neutrophil and its surface molecules 4 8.50E-03
Biocarta Monocyte and its surface molecules 4 1.80E-02
Gene Ontology Wound healing 5 9.40E-02
doi:10.1371/journal.pone.0011485.t002
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addition, 5 genes involved in differentiation of T and B lymphocytes
cells were found to be involved in the «Hematopoietic cell lineage»
pathway (p=4.2610
22). Surprisingly, genes involved in the
spreading of inflammation were grouped together. Usually, this
process can not be clearly visualized because of the very short period
of time between activation of the inflammatory and immune and
anti-inflammatory response.
Functional annotation analysis of genes belonging to the cluster
Late showed an over-representation of GO terms related to
transcription, metabolism and in particular lipid metabolism
(figure 5 and supplementary table S1). The Functional Annotation
Clustering tool from DAVID identified 3 groups of genes with the
highest enrichment scores. The first one (enrichment score =2.07)
showed an over-representation of GO terms related to «Transcrip-
tion» (p=1.4610
23), such as «Regulation of transcription»
(p=1.1610
23) or «Regulation of nucleobase, nucleoside, nucleotide
and nucleicacidmetabolic process» (p=7.7610
24). Mostof theGO
terms grouped in the second annotation cluster (enrichment
score =1.96) were found to be involved in metabolism, such as
«Metabolic process» (p=2.2610
23) or «Cellular metabolic process»
(p=2.3610
23). The third annotation cluster (enrichment score =
1.44) included GO terms related to lipid metabolism such as
«Cholesterol metabolic process» (p=9.3610
23) or «Cellular lipid
metabolic process» (p=5.2610
22). Increased expression level of
genes involved in transcription is a consequence of the metabolism
which is highly perturbed. Multiple alterations in lipid and
lipoprotein metabolism have been previously described associated
with infection and inflammation [16]. Here, we observed that
disturbance of genes expression levels related to lipid metabolism is
associated only with inflammation.
We also considered genes of interest for clinical studies such as
Smad7 [17]. In our study, Smad7 belongs to the set of significantly
differentially expressed genes across time and it belongs to cluster
Late. Its expression level increased between 3 hours and 4 hours
after OA injection to reach a maximum expression level 24 hours
after injection. We also considered the angiotensin-converting
enzyme gene (Ace) [18–19]. In our study, Ace expression level did
not significantly change over time. Finally, we considered
transcription of genes involved in surfactant lipid biosynthesis
and surfactant-associated proteins. In a previous study, authors
quantified expression levels of 5 genes involved in the surfactant
lipid biosynthesis and 5 genes involved in the surfactant-associated
protein biosynthesis [20]. Expression levels of these genes
decreased significantly in mice developing ALI. Out of these 10
genes, 4 are present on MUSV29K: Slc34a, Fasn, Sftpd and
Napsa. In our study, Slc34a, involved in surfactant lipid
biosynthesis, is the only gene whose expression level changed
significantly over time. It belongs to the cluster Late and its
expression level increased over time after OA injection to reach a
peak at 24 hours incubation.
Overall, our gene expression analysis revealed marked changes
in pathways involved in the immune and inflammatory responses,
and also lipid metabolism and transcription. First, the pro-
inflammatory phase is activated with high expression level of genes
involved in inflammation and immune response. Then, inflam-
mation is spreading into inflamed tissues. And, later, transcription
is activated and lipid metabolism seems highly disturbed.
Discussion
Data summary
In this study, we have searched for genes and physiological
pathways potentially involved in ALI. To this purpose, we
analyzed differentially expressed genes in lung from C57BL/6J
mice at different stages of inflammation. We found that injection
of OA deeply alters gene expression. In particular, we identified 3
clusters of genes specifically highly expressed either at early time-
points (early-inflammatory stage), at late time-points (late-inflam-
matory stage), or at the time-points when the shift between early-
and late-inflammatory stages occurs. In order to identify genes
whose changes in expression levels are associated with lung
inflammation, we performed a three class SAM procedure with a
stringent false discovery rate of 5%. The procedure was conducted
on the whole dataset. Because the technical procedure may affect
the gene expression level, we adjusted the measurements of mice
treated with OA to that treated with physiological serum. Thus,
we identified 1000 genes differentially expressed between OA mice
and physiological serum mice.
Limits of the OA model
In this study, our first aim was to define a model of lung
inflammation in mouse using OA. Despite its widespread use, the
OA-induced ALI model has not been standardized. One to 2 ml
of OA generates ALI when injected as a single bolus directly into
the pulmonary circulation to an animal weighing 25 Kg [10].
However, both smaller and larger doses have also been used. At
other times, the injection has been given in fractions, after
sonication in saline, after OA dissolution in ethanol, or as
continuous infusion. Each of these variations may alter the severity
or extensiveness of the injury, resulting in different physiopatho-
logic consequences. For example, Zhou et al. determined that an
intravenous dose of 0.15 mL/g body weight OA in mice resulted in
an approximate 24-hour survival rate of 75% [12]. Sixty minutes
after OA injection, they observed severe alveolar damage with the
development of alveolar edema, increased-permeability and
abnormalities in oxygenation. Using doses of OA that were up
to approximately 1.5 times the dose used by Zhou et al., Ulrich
et al. reported similar histopathological findings 1 hour after OA
injection in mice [13]. A dose-related difference in mortality was
observed in animals treated with 0.2 and 0.4 mL/g of OA
administered through the tail vein, respectively. The higher dose
was associated with 100% mortality, 30 to 40 minutes following
OA administration.
Previous studies showed that a time-course ranging from 40 to
90 minutes was required to detect an inflammatory response [12].
The length of the incubation period required to detect a pro-
inflammatory profile (expression levels of pro- and anti-inflamma-
tory cytokine or lung histology) depended on the OA dosage. As
mechanical ventilation induces by itself an inflammation [21], one
can hypothesize that models using mechanical ventilation
increased the inflammatory response. Given the contradictory
results previously published regarding the kinetics of inflammation
in mice, we quantified mRNA levels of pro- and anti-inflammatory
cytokines before performing high-throughput gene expression
analysis. Cytokines play a critical role as signaling molecules that
initiate, amplify, and perpetuate inflammatory responses on a local
and systemic basis.
Timing of inflammation
We quantified expression levels of 4 cytokines 1 hour,
1.5 hours, 3 hours, 4 hours, 18 hours and 24 hours after OA
incubation. Tnfa, Il6, Il10 and Il4 are commonly used to
specifically study pro- and anti-inflammatory phases (figure 1)
[22].
Tnfa is an early response cytokine. It plays an important role in
immunity and inflammation, in the control of cell proliferation,
differentiation and programmed cell death [23]. We found that, in
Gene Expression of ALI in Mice
PLoS ONE | www.plosone.org 6 July 2010 | Volume 5 | Issue 7 | e11485Figure 5. Functional annotation enrichment of the 366 genes belonging to cluster Late. Expression levels of genes belonging to cluster
Late increases 3H-4H after OA injection and reach a peak after 18H to 24H incubation. A- Distribution of the 366 genes belonging to Cluster Late into
the 3 main annotation clusters identified by the functional annotation clustering tool from DAVID: Transcription, Metabolic process and Lipid
metabolic process. B- 21 genes in cluster Late belong to the lipid metabolic process. These genes can be assigned to one or several of 7 GO
categories related to Lipid metabolism. Three of them also belong to 3 PIR categories (Protein Information resources) related to lipid metabolism. Red
means the gene belong to the pathway and Blue means that the gene does not belong to the pathway.
doi:10.1371/journal.pone.0011485.g005
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60 to 90 minutes after OA injection (figure 1 B). This corresponds
to the pro-inflammatory response.
Il6 is produced by a wide range of cells including monocytes/
macrophages, endothelial cells, fibroblasts, and smooth muscle
cells in response to stimulation by endotoxin [24]. Raised levels of
Il6 have been described in a number of acute conditions such as
burns, major surgery and sepsis [25]. Il6 is a ubiquitous cytokine
playing a role on pro- and anti-inflammation. Several experimen-
tal models suggest a protective role for Il6 against inflammation
[26]. Pro-inflammatory effects of Il6 have been shown in several
tumor cell lines [27]. Il6 is also involved in the spreading of pro-
inflammatory cells [28]. In our study, expression level of Il6 is
maximum 3 hours after OA injection, interconnecting the pro-
and anti-inflammatory phases (figure 1 C).
Il10, an anti-inflammatory cytokine [29], inhibits the release of
pro-inflammatory cytokines such as Tnfa from monocytes/
macrophages, thus preventing subsequent tissue damage [30].
The role of Il10 is essential to counter balance the pro-
inflammatory response. In a previous study, Park et al. found a
disproportionate anti-inflammatory response to the early pro-
inflammatory response, which leads to ARDS [31]. In our study,
Il10 expression increased from 3 hours and peaked 4 hours after
OA injection which corresponds to the anti-inflammatory response
to Tnfa (figure 1 D).
Il4 is also an anti-inflammatory cytokine which down-regulates
local levels of pro-inflammatory cytokines and chemokines [32].
We found that its production was simultaneous with Il10
expression peak. This finding confirms the timing of the anti-
inflammatory phase (figure 1 E).
The quantification of expression levels of 4 pro- and anti-
inflammatory cytokines by real-time PCR allowed us to identify
two phases during inflammation. We identified the pro-inflam-
matory phase based on the high expression level of Tnfa 1.5 hours
after OA injection. Later, 3 to 4 hours after OA injection, anti-
inflammatory cytokines Il10 and Il4 are highly expressed.
Meantime, Il6, which has pro- and anti-inflammatory activities,
is highly transcribed 3 hours after OA injection. Given the
contradictory results previously published, this preliminary step
was essential to timely identify pro- and anti-inflammatory phases
in our model and then perform large-scale transcriptional study
considering each phase of inflammation described.
An early inflammatory and immune response
Once our mouse model of lung inflammation settled, we
identified molecular pathways associated with lung injury.
Injection of OA rapidly affects the expression of genes involved
in the defense response such as inflammatory and immune
responses. Expression level of numerous chemokines such as
Cxcl5, Ccl22, Ccl4, Ccl3, Ccl6 or Ccl25 increased rapidly and
allowed recruitment of specific leukocyte subpopulations to sites of
tissue damage (see supplementary data file S4) [33]. The
expression of pro-inflammatory cytokines and chemokines has
been previously observed in transcriptional studies of infection in
model organisms. Calvano et al. showed, in human blood
leukocytes, an over-expression of pro-inflammatory chemokines
2 hours to 4 hours after endotoxin administration [34]. The
activation of cytokines following inflammation has also been
observed in lung by Chinnaiyan et al. in a transcriptional study of
systemic inflammation in a cecal ligation/puncture model of sepsis
in rat [35]. Also, the MAPK signaling pathway, involved in cell
proliferation, differentiation and inflammation is activated (see
supplementary data file S4) (figure 6). Three regulated groups of
MAPK are activated: the extracellular signal-related kinases
(ERK) with genes such as Fgf1, Rasa2, Ras, Dusp1, Mknk1,
Mknk2 or Rps6ka3; the Jun amino-terminal kinases (Mapk8,
Mapk9, Mapk10) with Il1, Map4k1, Pak1, Pak2 and Dusp1; and
the p38 proteins with Il1, Map3k7ip1, Map3k7ip2, Dusp1 and
Map3k6. Il1b is known to participate in ARDS pathogenesis [36].
The MAPK cascade pathways are critical for the transmission of
activated cell surface receptor signals to invoke multiple regulated
intracellular processes. We also noticed over-expression of Il15ra
which blocks Il15, an inhibitor of Tnfa [37]. Activation of
inflammatory and immune responses early after OA injection
validates our inflammation model in mouse [23].
An intermediate spreading of inflammation
The transition phase at 3 hours –4 hours which followed the
pro-inflammatory phase corresponds to the spreading of inflam-
mation. Among genes whose expression level reaches a maximum
at this time-point, we found transmembrane adhesion molecules
(Cd44, Pecam1 and Icam1) as well as endothelial cell adhesion
molecule (CAM) (Cd34, Icam1, Glycam1 and Pecam1) (see
supplementary data file S4) [37–38]. It has been previously shown
that CAM adhesion molecules are strongly involved in the
inflammatory process by modulating the leukocyte trafficking
[38–39]. B and T cell lymphocytes interact with a variety of cells
as part of their immune function allowing inflammatory signals to
circulate between organs. The interaction of lymphocytes with
other cell types like vascular endothelial cells requires transmem-
brane adhesion molecules. Each of these lymphocyte adhesion
molecules interacts with specific ligands expressed on cells like
endothelial cells to moderate adhesion between cells. Cd44 is an
adhesion molecule with several roles, including interaction of
leukocytes with endothelial cells in response to inflammation [40].
Pecam1 mediates the spreading of monocytes and other immune
cells into inflamed tissues through interaction with vascular
endothelial cells [41]. Expression of intercellular adhesion
molecule-1 (Icam1) is increased by inflammatory signals, leading
to higher adhesion and permeation of lymphocytes into inflamed
tissues. Icam1 is an inducible protein expressed on the surface of
endothelial cells. Under physiological conditions, Icam1 is not
constitutively expressed, or is expressed at low levels in most
tissues. In inflammatory states, it has been shown that expression
level of Icam1 is up-regulated by Tnfa [42]. It has been shown that
increased expression of Icam1 protects lung against injury by
neutralizing antibodies or targeted gene deletion during bacterial
sepsis, acute pancreatitis and trauma [43]. As Icam1 deficiency
interferes with neutrophil recruitment, these results support the
concept of a therapeutic strategy directed against neutrophil
migration and activation. During inflammation, leukocytes bind
to endothelial CAM and then migrate across the vascular
endothelium.
There is a clear link between blood and inflammation as blood
carries the inflammation throughout the entire organism. We
found, in cluster Intermediate, 9 genes such as Cd34, Cd44, Il7r,
Csf1 and Cd38 leading to differentiation of blood cells (see
supplementary data file S4). Blood-cell development progresses
from an hematopoietic stem cell which can differentiate into
several lineages such as T lymphocytes, B lymphocytes, NK cells,
erythrocytes or platelets. Cells undergoing this differentiation
process express a stage- and lineage-specific set of surface markers.
Therefore cellular stages are identified by the specific expression
patterns of these genes. Cd34 is an adhesion molecule with a role
in early hematopoiesis by mediating the attachment of stem cells to
the bone marrow extracellular matrix or directly to stromal cells
[44]. Cd44 is involved in lymphocyte activation [40]. Il7r is the
receptor of Il7 which is involved in the regulation of lymphopoi-
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Il7r [45]. Csf1 induces cells of the monocyte/macrophage lineage
[46].
We were able to visualize the spreading of inflammation as
many genes involved in leukocyte transendothelial migration and
CAM clustered together. Spreading of inflammation is part of the
pro-inflammatory response to inflammation. We observed that
high expression level of genes involved in the spreading of
inflammation signal follows the high expression level of genes
involved in inflammation and immune processes. This is probably
due to the fact that vascular endothelium is the target of pro-
inflammatory cytokines. Once the vascular endothelium activated,
genes involved in cell adhesion are expressed and leukocytes are
transferred from circulating blood to the site of inflammation.
A late disruption of lipid metabolism
In our study, we found a late disruption of gene expression level
related to lipid metabolism. Indeed, among numerous genes whose
expression level increases at 3 to 4 hours and reach a peak at
18 hours–24 hours, 21 belong to the lipid metabolic process
(figure 5 and see supplementary data file S4). Previous studies
showed lipid metabolism disturbance soon after inflammation
started. Hardardottir et al. have proposed that the changes in lipid
and lipoprotein metabolism that occur during the host response to
infection/inflammation include anti-infective and anti-inflamma-
tory effects that contribute to the host defense [47]. Infection and
inflammation are accompanied by cytokine-induced alterations in
lipid and lipoprotein metabolism [48]. As expression level of
numerous genes involved in lipid metabolism increased 3 to
4 hours after OA injection and are highly over-expressed 24 hours
after OA injection, we believe that lipid metabolism disruption is
related to the highly transcribed pro-inflammatory cytokines such
as Tnfa and Il1. Indeed, we observed that expression level of Tnfa
is maximum 1.5 hours after OA administration (figure 1 B) and
Il1, which belongs to cluster Early, is highly expressed 1 hour–
1.5 hours after OA administration (figure 4). Il6 is highly
expressed 3 hours after OA injection. Moreover, it has been
previously shown that serum triglyceride levels, serum total
cholesterol and LDL levels increased as a consequence of the
highly transcribed pro-inflammatory cytokines [47,49]. Simulta-
neously, during inflammation, there is a marked decrease in serum
levels of HDL [50]. We do not believe that high expression level of
genes involved in lipid metabolism is a direct consequence of OA
itself. Indeed, even if OA belongs to the fatty acid family, several
studies have shown that late disruption of the lipid metabolism is
associated with inflammation. Worgall, for example, showed that
expression of defective cystic fibrosis transmembrane conductance
regulator (CFTR), the cause for cystic fibrosis, is associated with an
inflammatory state and affects fatty acid and cholesterol
metabolism which is associated, in great majority of patients, with
decreased linoleic acid level and increased myristic, palmitoleic,
stearic and oleic fatty acids levels [51]. Recently, there has been
Figure 6. MAPKinase Signaling Pathway. The 3 major groupings of mitogen-activated protein kinase (MAPkinase) pathways are activated
rapidly after OA injection. Genes belonging to the extracellular signal-related kinases (ERK) (blue), the Jun amino-terminal kinases (pink) and the p38
proteins (green) are up-regulated early after OA injection. These genes are represented in bold.
doi:10.1371/journal.pone.0011485.g006
Gene Expression of ALI in Mice
PLoS ONE | www.plosone.org 9 July 2010 | Volume 5 | Issue 7 | e11485much interest in using Statin for sepsis [52]. Statin, which has
lipid-lowering properties, reduce total cholesterol, LDL and
triglyceride levels [53]. These previous works showed that triggers
of inflammation which are not fatty acids led to disruption of lipid
metabolism. Feingold et al. observed that the hypertriglyceridemic
effect of LPS and cytokines is rapid, occurring 2 hours after
administration and is sustained for at least 24 hours [16].
Channaiyan et al. showed, in a transcriptional study of systemic
inflammation in a cecal ligation/puncture model (CLP) of sepsis in
rat, that several genes involved in lipid metabolism are up-
regulated in lung 6H after CLP [35]. In our study, the timing of
the cytokine effect on genes related to lipid metabolism is similar.
We showed here that lipid metabolism disturbance is a
consequence of inflammation.
Most of the changes in genes related to lipid metabolism that are
induced by inflammation are attributable to changes in gene
transcription. The expression level of 189 genes involved in at least
one out of the 25 GO categories belonging to the transcriptional
process are part of the annotation cluster 1 identified by DAVID.
They slowly increased 3 hours to 4 hours after OA injection to
reach a maximum expression level after 18 hours to 24 hours OA
incubation (supplementary table S1). This is probably the
consequence of the high expression level of many pro-inflamma-
tory cytokines identified in cluster Early (figure 5). In the promoter
region of Il6 and Il1, transcription factors Nfkb1 and Cebpb (NF-
IL6) are involved in the expression of many inducible cellular
genes that encode cytokines, immunoregulatory receptors, and
acute phase proteins [50]. Because many genes involved in
regulating immune response and acute phase reaction contain
both Cebpb and Nfkb1 sites, it is highly possible that cooperative
interactions between Cebpb and Nfkb1 play an important role in
the expression of cytokines. For many positive acute phase
proteins, transcription activities of their corresponding genes
increase during inflammation, reaching a maximum level between
18 hours and 36 hours after inducing an acute inflammation [54].
Our results confirm these findings. Indeed, pro- and anti-
inflammatory cytokines highly expressed respectively at early
and late stages of the inflammation process induce the transcrip-
tion of many other genes later after OA injection. Also, Calvano et
al. showed in their microarray study in 2005 that, in human blood
leukocytes, 4 hours to 6 hours after endotoxin injection, the
expression of numerous transcription factors was increased.
Among them, the expression of several members of the nuclear
factor kappa/relA family of transcription factors (Nfkb1, Nfkb2,
Rela, and Relb) reached their zenith [34].
We expected a massive release of inflammatory mediators soon
after OA injection followed by the release of anti-inflammatory
mediators [55]. This sequence of events has been previously
described by authors studying sepsis [56]. The response to
inflammation we observed and which lasted over 24 hours has
been previously described associated with infection [47]. Observ-
ing these responses associated with only inflammation justifies the
need to fully describe gene expression profiles during inflammation
and therefore, it will become possible for other research groups to
identify specific responses to infections during sepsis.
Potential targets for therapy
By looking at how changes in gene expression occur through
time during lung inflammation, we could confirm or invalidate
targets previously identified for therapy.
Among these candidates, Smad7 has been identified [57].
Transient gene transfer and expression of Smad7, introduced by
recombinant human type 5 adenovirus vector into the lungs,
prevented pulmonary fibrosis induced by bleomycin in mice [57].
Smad7 is an intracellular antagonist of Tgfb signaling [57]. It
inhibits Tgfb-induced transcriptional response. Moreover, it is
thought that prolonged overproduction of Tgfb induced by
repeated chemical or biological injury leads to the accumulation
of pathological amounts of extra-cellular matrix in the lung tissue,
which is followed by functional deterioration [17]. We believe
Smad7 is a good candidate for gene therapy because it belongs to
the set of significantly differentially expressed genes across time
and its expression level increased 3 to 4 hours after OA injection
to reach a maximum expression level 24 hours after injection.
We also considered the angiotensin-converting enzyme gene
(Ace) which can predict susceptibility and outcome in ARDS.
Circulating Ace derives largely from the pulmonary endothelium.
Its release in circulation is affected by extensive endothelial
damage [18]. Septic ARDS patients have markedly decreased
serum Ace levels compared to those of non-septic ARDS patients
[19]. In our non-septic model of ALI, Ace expression level did not
significantly change over time.
Finally, we considered transcription of surfactant lipid and
surfactant-associated proteins. During ALI in mice, epithelial cell
injury leads to reduced surfactant biosynthesis. It has been
previously shown that maintenance of surfactant-associated
protein B (Sftpb) transcript levels is necessary for over-expression
of mouse transforming growth factor a (Tgfa) involved in
protection against nikel-induced lung injury [20]. Out of the 10
candidate genes previously identified, 4 are present on
MUSV29K: Slc34a, Fasn, Sftpd and Napsa. In our study, Slc34a,
involved in surfactant lipid biosynthesis, is the only gene whose
expression level changed significantly over time. It belongs to the
cluster Late and its expression level increased over time after OA
injection to reach a peak at 24 hours incubation.
Our wide-scale transcriptional study identified pathways and
specific genes involved in response to inflammation. We found
several potential candidates for gene therapy such as Smad7. Since
there has been great progress in delivering genes to the lungs over
the past decade, gene therapy is expected to become a new tool in
addition to classical approaches for treating inherited and acquired
diseases including ARDS in the near future.
Conclusion
In this study, we pictured gene expression profiles during
inflammation according to the time-course. Overall, our micro-
array analysis gives a global overview of critical events occurring
during lung inflammation. We have first confirmed that gene-
expression profiling discriminates between pro- and anti-inflam-
matory phases during lung inflammation. The analysis of gene
functional annotation reveals several major features. First, it
visualizes at transcription level the pro-inflammatory stage
characterized by the release of immune response and activation
of inflammatory mechanisms. We observed that these pathways
are activated soon after the initiation of lung injury. Then the
Intermediate cluster revealed that the immune cells migrate into
inflamed tissues through interaction with vascular endothelial cells.
Finally, at late stage of the inflammation, metabolism is deeply
disturbed. We also showed here that inflammation is associated
with marked changes in lipid and lipoprotein metabolism
suggesting that lipoproteins seem to participate in innate
immunity.
This inflammation model in mouse is the first step toward the
identification of the molecular mechanisms involved in the
infection process at different steps of inflammation. From now
on, when studying the impact of an infection at the transcriptional
level, we will be able to distinguish between the gene expression
level variations due to the pathogen itself and the ones resulting
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study, by identifying numerous common pathways, we showed
that the inflammation alone which is a component of infection has
to be considered separately from infection.
Furthermore, it is reasonable to think that the impact of a
pathogen on an inflamed organ depends on the pre-existing
inflammation. Inoculation of an infectious agent has to take into
account timing of the pre-existing inflammation (pro- or anti-
inflammatory stage). We reached our first objective of character-
izing inflammation across a time-course. Next, we will induce an
infectioninmouseundergoinginflammationat differenttime-points
(pro- vs. anti- inflammatory phases) using group B streptococcus.
Materials and Methods
Experimental groups
Wild-type female C57Bl/6J mice, 7 weeks old, were obtained
from Charles River and housed in a specific pathogen-free animal
facility. We studied 35 mice divided into 6 groups (figure 7). Each
group included one or two mice administered with physiological
serum and 3 to 7 mice administered with OA, which correspond to
biological replicates. Each group was identified according to the
incubation time: 1 hour, 1.5 hours, 3 hours, 4 hours, 18 hours
and 24 hours. All experimental procedures involving animals were
approved by the veterinary office of the Ministry of Agriculture,
France (authorization number: 13–27).
Injections
Female C57Bl/6J mice were anesthetized with 5% Xylazine–
20% Ketamine (0,1 ml/10 g). We injected 20 ml of physiological
serum in the control mouse at each time-point and 20 mlo fO A
(1,2 ml/g body weight, sigma #27728-1L-R) in the other 27 mice
of our study. Administration of physiological serum and OA was
done through the tail vein with a 0.3-ml insulin syringe (BD
#320837).
Sacrifice and organ removal
Each group of mice was sacrificed 1 hour, 1.5 hours, 3 hours,
4 hours, 18 hours or 24 hours after injection of OA or
physiological serum by exanguination through the eye vein. For
each mouse, we collected the smallest lung for RNA extraction in
4 ml Trizol. The lung was immediately fractionated using a
polytron (T8 Ultra-Turrax, IKA WERKE #3420000) and kept at
220uC.
Lung histology
The lung was fixed in 4% Paraformaldehyde and paraffin
embedded. Five mm sections were cut and stained with Harri’s
hematoxylin and eosin (H&E) for morphological examination.
Lung inflammation was assessed by studying the following
morphological criteria: alveolar/interstitial edema, presence of
fibrin, alveolar/interstitial neutrophils. All slides were coded and
evaluated in a blinded fashion to prevent bias.
RNA extraction
Total RNA from lung was extracted using TRIzol reagent
(Invitrogen, #15596-026). The quality of RNA was confirmed on
a 1% denaturing agarose gel, and the concentration of RNA was
determined by reading absorbance at 260/280 nm.
Real-Time PCR
Real-time RT-PCR amplification was performed using primer
sets for one control gene: Actb (59-ACTCTTCCAGCCTTCC-
TTC-39 and 59-ATCTCCTTCTGCATCCTGTC-39), two pro-
inflammatory genes: Tnfa (59-CCCTCACACTCAGATCATCT-
TCT-39 and 59-GCTACGACGTGGGCTACAG-39) and Il6 (59-
TAGTCCTTCCTACCCAATTTCC-39 and 59-TTGGTCCTT-
AGCCACTCCTTC-39), and two anti-inflammatory genes: Il10
(59-GCTCTTACTGACTGGCATGAG-39 and 59-CGCAGCT-
CTAGGAGCATGTG-39) and Il4 (59-TGGATCTGGGAG-
CATCAAGGT-39 and 59-TGGAAGTGCGGATGTAGTCAG-
39). cDNA was synthesized using 5 mg of RNA, 1 mM dNTP,
and1 mg dt25 primer. After 5minutes at 65uC, 10 mM DTT, 40 U
RNAaseIN (Promega,#N261B) and 400U of Superscript II
transcriptase (Invitrogen, #18064-014) were added. This mix
has been maintained 2 hours at 42uC and 15 minutes at 70uC.
1 ml of RNAaseH (Invitrogen,#18021-014) has then been added
and the samples have been kept at 37uC for 20 minutes. 1 ml of the
RT product was then amplified for 2minutes at 50uC, 10minutes
at 95uC followed by 40 cycles (15 sec at 95uC, 30 sec at 60uC,
30 sec at 72uC) followed by one cycle of 72uC for 10minutes and
95uC for 15 sec. This was done in a 25 ml reaction mix containing
Figure 7. Experimental design of the experiment. We studied 35 mice C57BL6/J, female, 7 weeks old. We divided these mice into 6 groups
based on the incubation time (1H, 1H30, 3H, 4H, 18H, and 24H). In each group, mice are divided into 2 subgroups depending on the injection: OA or
physiological serum. 25 samples have been hybridized on 2 microarrays consisting in technical replicates and 10 samples have been hybridized once.
We performed 60 hybridizations.
doi:10.1371/journal.pone.0011485.g007
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#4367659) and 25pM of each primer using the ABI PRISM 7000
sequence Detection System (Applied Biosystem).
Relative expression of the RT-PCR products was determined
using the comparative CT method based on the mathematical
model from M.W. Pfaffl [58]. Relative expression values for each
pro-inflammatory and anti-inflammatory gene were expressed as a
ratio of pro/anti-inflammatory gene expression level after OA
injection to the same pro/anti-inflammatory gene expression level
after physiological serum at the same time-point. Each sample was
run in triplicate. At least 2 negative controls without template or
with lung RNA were systematically conducted with each
amplification.
Microarray design
cDNA microarrays were designed and prepared as described by
Puthier et al. [59]. The microarrays used in this study, MUSV29K,
contain 7771 sequences. The following cDNA libraries were used:
the NIA Mouse 15K cDNA clone set, 2NbMT (thymus), NbMLN
(lymph node), and 3NbMS (spleen). Detailed descriptions of these
cDNA libraries are available at the UniGene database website
(2NbMT: Lib.544, 3NbMS: Lib. 553, NbMLN: Lib.567, NIA
15K: Lib. 8622) [60]. All of the libraries were cloned into
pT3T7D-Pac vector, except for the NIA 15K Mouse cDNA clone
set, which was cloned into pSPORT1 vector. The NIA 15K
Mouse cDNA clone set is a re-arrayed and resequenced set of 15
000 bacterial clones derived from 11 embryo cDNA libraries [61].
2NbMT, NbMLN and 3NbMS are sequenced I.M.A.G.E
libraries. These libraries contain 84127 clones. We used the
Microarrays Quality Control tool to select clones matching a
single region on the mouse genome and for which at least one 39
EST and one 59EST have been identified [62]. We selected 7771
bacterial clones matching 6622 mouse genes. 73% (4833) of the
genes are represented by a single cDNA clone and about 27%
(1789) of the genes included in this gene set are represented by two
or more different cDNA clones, providing internal controls to
assess the reproducibility of gene expression measurements. We
also added 8 positive controls (poly-A LBP2S and Cot1, a mix of
DNA fragments containing repeated sequences) and 2205 negative
controls (empty spots and CG03, an Arabidopsis thaliana cDNA
sequence). In summary, the MUSV29K mouse microarray we
designed contains 9984 spots, identifying 6622 mouse genes.
Microarray preparation
PCR amplifications were performed in 96-well microliters plates
using the following primers: 59-CCAGTCACGACGTTG-
TAAAACGAC-39 and 59-GTGTGGAATTGTGAGCGGATA-
ACAA-39. The reactions were performed as described in Diehl et
al. [63] by transferring few Escherichia coli from a growth culture
with a plastic 96pins replicator (Proteigene, #X5055) to 100 mlo f
PCR mix pH 8,5 containing 1,5 mM MgCl2, 1 M Betain,
375 mM dATP, dTTP, dGTP, dCTP, and 5 U of GoTaq DNA
polymerase (Promega, #M3171). The plates were incubated for 6
min at 94uC, before 38 cycles of 94uC for 30 seconds, 65uC for 45
seconds and 72uC for 3.5 minutes, followed by a final elongation
phase at 72uC for 10 minutes. Amplification products were not
quantified, but their quality was systematically checked on 1%
agarose gels. 11,03% of the bacterial clones were estimated to be
non-amplified and 4,38% showed multiple bands after PCR
amplification. Unpurified PCR products were then transferred to
384-well microplates using the TECAN Genesis workstation 150,
before being evaporated. Each well was filled with 30 ml of distilled
water, and its content spotted onto nylon membranes (Hybond-
N+; Amersham Bioscience). This step was conducted using a
MicroGrid-II arrayer (Apogent Discoveries) equipped with a 64-
pin biorobotics printhead. Microarrays were hybridized with
xdATP 33P-labelled probe, whose oligonucleotide sequence is
common to all spotted PCR product (LBP2S 59-TCACACAG-
GAAACAGCTATGAC-39). It showed uniform signal intensities
across individual membranes [64].
Microarray data acquisition and analysis
10 mRNA samples extracted from 10 mice were run on a single
microarray. In addition, 25 samples were run on two microarrays,
and were considered as technical replicates. This corresponds to a
total of 60 microarrays. All microarray procedures were done at
our microarray core facility [65]. CDNA were designed and
prepared as described in Puthier et al. [59], using 5 mg of total
RNA in the presence of a-dCTP 33P.
After image acquisition, data were processed as described in
figure 3. Hybridization signals were quantified using the Bzscan2
software [66]. All images were carefully inspected and spots with
overestimated intensities due to neighborhood effects were
manually excluded. We used the NylonArray library for R locally
developed by A. Bergon and D. Puthier [67]. This package contains
functions to perform diagnosis and normalization of nylon
microarray data. For each microarray, we obtained two datasets:
the first was obtained by hybridizing the microarray with a probe,
whose oligonucleotide sequence is common to all spotted PCR
product (vector) and the second was obtained by hybridizing the
microarray with lung cDNA (sample). The sample datasets were
corrected for neighborhood effects and local background as
described by F. Lopez et al. [66]. Quantile normalization was
applied to sample data to correct for global intensity and dispersion.
Microarray data were statistically analyzed using the TIGR
MeV (MultiExperiment Viewer) V4.3.01 software [68]. SAM
(Significant Analysis of Microarrays) procedure was applied to look
for time specific variation in gene expression in the dataset [14]. A
each time-point, mean value of gene expressions in control
samples (physiological serum injection) were subtracted from gene
expression in OA samples. Hierarchical clustering (average linkage
clustering metrics and Pearson correlation for the distance) was
applied to the dataset (samples and genes) using the Cluster
software and results were visualized with the Treeview software
[15]. We identified biological annotation for the clusters using
DAVID [69] and interaction networks using the Kegg pathways
[70]. We applied a Bonferroni correction to account for multiple
tests performed. To interpret our data, we used two functionalities
in DAVID: the «Functional annotation» tool and the «Functional
annotation clustering» tool. The first one associated gene ID with
a biological term which belongs to one out of the 40 annotation
categories available in DAVID, including GO terms, protein-
protein interactions, protein functional domains, diseases associ-
ations and sequence feature. This extended annotation coverage
increases the analytic power by allowing investigators to analyze
their genes from many different biological aspects in a single space.
DAVID functional annotation clustering measured relationships
among the annotation terms based on the share of common genes.
This type of grouping of functional annotations was able to give a
more insightful view of the relationships between annotation
categories and terms compared with the traditional linear list of
enriched terms, as highly related/redundant annotation terms
may be dispersed among hundreds of other terms. Each cluster of
functional annotation was associated with an enrichment score,
which depended on the distribution of the enrichment (p-values) of
each member. A good enrichment score was obtained when most
of members had good p-values. This score is a relative score
instead of a statistical probability with a minimum and a
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considered only together, by comparing them.
All data are MIAME compliant and have been submitted to the
GEO database (http://www.ncbi.nlm.nih.gov/geo/; accession
number GSE18712).
Supporting Information
Data file S1 Comparison of FDR5% and FDR0% to identify
significantly differentially expressed genes. In our study, we
applied a false discovery rate of 5%, which yielded to a set of
1000 genes significantly differentially expressed across the time-
course of our experiment. By filtering our data based on q,0.01
and FDR 5%, we end up with 121 genes significantly differentially
expressed in our experiment. By applying a false discovery rate of
0%, we identify 121 genes significantly differentially expressed
across the time-course and identical to the ones identified with
FDR 5% and q,0.01.
Found at: doi:10.1371/journal.pone.0011485.s001 (0.14 MB
PDF)
Data file S2 One thousand genes have been identified by SAM
with FDR 5%. Each gene is associated with its expression values in
OA samples. Each expression value has been normalized by
quantile and adjusted with its physiological serum value at the
same time point.
Found at: doi:10.1371/journal.pone.0011485.s002 (0.40 MB
TXT)
Data file S3 Identification of clusters of samples using
hierarchical clustering. Prior to partition samples (=microarrays)
into 3 classes (early, intermediate and late), we performed a
hierarchical clustering of the samples in TMEV V4.3.01. using
average linkage clustering metrics and Pearson correlation for the
distance. This analysis partitioned the samples into 3 groups: early
(1H-1H30), intermediate (3H-4H) and late (18H-24H).
Found at: doi:10.1371/journal.pone.0011485.s003 (0.14 MB
PDF)
Data file S4 Sample of interesting genes differentially expressed
across the time-course. For each cluster, a set of genes mentioned
in the manuscript is listed associated with their average expression
level at each time-point.
Found at: doi:10.1371/journal.pone.0011485.s004 (0.00 MB
TXT)
Table S1 Functional annotation and enrichment of the 366
genes belonging to cluster Late. We identified biological
annotation for the cluster Late using DAVID [69] and interaction
networks using the Kegg pathways [70]. We applied a Bonferroni
correction to account for multiple tests performed. The functional
annotation functionality associated gene ID with a biological term
which belongs to one out of the 40 annotation categories available
in DAVID. DAVID functional annotation clustering measured
relationships among the annotation terms based on the share of
common genes.
Found at: doi:10.1371/journal.pone.0011485.s005 (0.05 MB
DOC)
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